Steven S. Pullen

3.4k citations

36 papers · 2.2k indexed · h-index 22

Nephrology top 2%
Cancer Research top 5%
- NF-κB Signaling Pathways 11
Immunology top 5%
- Immune Response and Inflammation 6
- interferon and immune responses 4
- Immunotherapy and Immune Responses 3
Molecular Biology top 10%
- Viral Infectious Diseases and Gene Expression in Insects 4
Oncology top 10%
Physiology
- Nitric Oxide and Endothelin Effects 4
Epidemiology
- Liver Disease Diagnosis and Treatment 4
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 3

Co-authors: Marilyn R. Kehry James J. Crute Thu Thi Dang Paul D. Friesen Sarah M. McWhirter Tom Alber Heather G. Miller Carine M. Boustany‐Kari
Cited by: Nephrology Cancer Research Immunology
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Virology (3 papers)Nature Medicine (2 papers)
Partner nations: United States Germany France

In The Last Decade

Steven S. Pullen

36 papers receiving 2.1k citations

Peers

Countries citing papers authored by Steven S. Pullen

Since Specialization

Citations

This map shows the geographic impact of Steven S. Pullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven S. Pullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven S. Pullen more than expected).

Fields of papers citing papers by Steven S. Pullen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven S. Pullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven S. Pullen. The network helps show where Steven S. Pullen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven S. Pullen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven S. Pullen Line = papers co-authored together Steven S. Pullen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) increases kidney disease risk by modulating ferroptosis Science Translational Medicine ·Muhammad Ilham Alhari,Katie Sullivan,Dhanunjay Mukhi,Magaiver Andrade-Silva,Hongbo Liu,Yuting Guan,Xiangchen Gu,Junnan Wu,Tomohito Doke,Daigoro Hirohama,Paolo Guarnieri,Jon Hill,Steven S. Pullen,Jay J. Kuo,Karl Johann Saldanha,Katalin Suszták	2025	3
2	Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction Nature Communications ·Kuo Du,David S. Umbaugh,Liuyang Wang,Ji Hye Jun,Rajesh Kumar Dutta,Genica Baczynski,Nanqi Ren,Qiaojuan Zhang,Dennis C. Ko,A. Wiegand,Jon Hill,Keita Kato,Steven S. Pullen,Vaibhav Jain,Simon G. Gregory,Manal F. Abdelmalek,Anna Mae Diehl	2025	11
3	Single‐cell RNA sequencing data identify a conserved population of metallothionein‐expressing macrophages that may be ubiquitous in vital human organs SHILAP Revista de lepidopterología ·Son Dong Woo,Francis J. Eng,Hunter Brzezinski,Vikas Gautam,Stephen C. Ward,Thomas D. Schiano,C. W. Wilsony,J. Mulders,Anthony V. Azzara,Steven S. Pullen,Paolo Guarnieri,Costica Aloman,Andrea D. Branch	2024	1
4	The senescence-associated secretome of Hedgehog-deficient hepatocytes drives MASLD progression Journal of Clinical Investigation ·Ji Hye Jun,Kuo Du,Rajesh Kumar Dutta,Raquel Maeso‐Díaz,Seh‐Hoon Oh,Liuyang Wang,Keita Kato,A. Wiegand,Jonathan R. Hill,Steven S. Pullen,Anna Mae Diehl	2024	13
5	The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease Journal of Pharmacology and Experimental Therapeutics ·Glenn A. Reinhart,Paul C. Harrison,剛今井,Kristen Buford,كهوس ، رشيد,Jon Hill,Hu Sheng Qian,Joseph Heston,壹图,Mayokun Ajeigbe,Hong Wang,F Vatalaro,Craig J. Ramlal,Jehrod Brenneman,Todd Bosanac,Diane Wong,Ryan M. Fryer,Jane Pleskunas,Carine M. Boustany‐Kari,Steven S. Pullen	2022	22
6	Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies Scientific Reports ·Fabian Heinemann,Peter Groß,Gerd Hesselmann,Hu Sheng Qian,Jonathan R. Hill,Anne Höfer,Danny Jonigk,Anna Mae Diehl,Manal F. Abdelmalek,Martin Lenter,Steven S. Pullen,Paolo Guarnieri,Birgit Stierstorfer	2022	24
7	Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease Cellular and Molecular Gastroenterology and Hepatology ·Tianyi Chen,George D. Dalton,Seh‐Hoon Oh,Raquel Maeso‐Díaz,Kuo Du,Rohan Kalpavruksha,Cynthia D. Guy,Manal F. Abdelmalek,Ricardo Henao,Paolo Guarnieri,Steven S. Pullen,Simon G. Gregory,Joseph Locker,J. Mark Brown,Anna Mae Diehl	2022	19
8	The key role of NLRP3 and STING in APOL1-associated podocytopathy Journal of Clinical Investigation ·Junnan Wu,Archana Raman,Nathan J. Coffey,Xin Sheng,CEL Educational Resources,Matthew J. Seasock,Ziyuan Ma,Pazit Beckerman,Dorottya Laczkó,Matthew B. Palmer,Jeffrey B. Kopp,Jay J. Kuo,Steven S. Pullen,Carine M. Boustany‐Kari,Andreas Linkermann,Katalin Suszták	2021	94
9	Renal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease Nature Medicine ·Chengxiang Qiu,Shizheng Huang,Jihwan Park,YoSon Park,Yi-An Ko,Matthew J. Seasock,В.А. Ларичев,Xiang‐Xi Xu,Wen-Chao Song,Matthew Palmer,Jon Hill,Paolo Guarnieri,Julie A. Hawkins,Carine M. Boustany‐Kari,Steven S. Pullen,Christopher D. Brown,Katalin Suszták	2018	146
10	Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice Nature Medicine ·Pazit Beckerman,Jing Bi‐Karchin,Ae Seo Deok Park,Chengxiang Qiu,Patrick Dummer,Irfana Soomro,Carine M. Boustany‐Kari,Steven S. Pullen,Jeffrey H. Miner,Chien-an A. Hu,Tibor Rohács,Kazunori Inoue,Shuta Ishibe,Moin A. Saleem,Matthew B. Palmer,Ana María Cuervo,Jeffrey B. Kopp,Katalin Suszták	2017	234
11	Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients PLoS ONE ·Denis Delić,雲岡梓,Ramona Schmid,Patrick Baum,Barb Hamilton-Hinch,Martin Gerl,Heike Zimdahl,Steven S. Pullen,Richard Urquhart	2016	189
12	A soluble guanylate cyclase activator protects from diabetic nephropathy beyond standard of care in the ZSF1 rat BMC Pharmacology and Toxicology ·Steven S. Pullen,剛今井,Paul C. Harrison,Kristen Buford,Hong Wang,壹图,HuSheng Qian,Diane Wong,Jane Pleskunas,Jehrod Brenneman,Ryan M. Fryer,Jeremy G. Richman,Glenn A. Reinhart,Carine Boustany	2015	2
13	Benzimidazolone as potent chymase inhibitor: Modulation of reactive metabolite formation in the hydrophobic (P1) region Bioorganic & Medicinal Chemistry Letters ·Wendell Tripp,Đoàn Ngọc Thắng,Jin‐Man Kim,Ming‐Hong Hao,Kevin Qian,Neil A. Farrow,R. Halcour,F Vatalaro,Richard D. Schneiderman,Elias August,Leslie Martin,Shimaa S Abdrabo,Steven S. Pullen,Hidenori Takahashi,Stéphane De Lombaert	2011	16
14	2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocket Bioorganic & Medicinal Chemistry Letters ·Wendell Tripp,Jörg Bentzien,G. Vounotrypidis,Steven S. Pullen,Xiao‐Peng Deng,Joseph R. Woska,Stanley Kugler,Mohammed A. Kashem,Hidenori Takahashi	2008	18
15	Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design Bioorganic & Medicinal Chemistry Letters ·Brian N. Cook,Jörg Bentzien,André White,Đoàn Ngọc Thắng,Ji Wang,Shcherbinin Ni,J. O. A MATIAS,Xiao‐Peng Deng,Mohammed A. Kashem,Stanley Kugler,John P. Wolak,Gregory P. Roth,Stéphane De Lombaert,Steven S. Pullen,Hidenori Takahashi	2008	29
16	5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk) Bioorganic & Medicinal Chemistry Letters ·Michael P. Winters,Gang Wang,Xiao‐Peng Deng,Steven S. Pullen,Joseph R. Woska,Ernest Raymond,Rosemarie Sellati,Charles L. Cywin,Roger J. Snow,Mohammed A. Kashem,John P. Wolak,Елена Логунова Витальевна,Paul V. Kaplita,Christopher Predel,نرگس روستایی,Renée L. DesJarlais,Gregory P. Roth,Hidenori Takahashi,K.J.M. Moriarty	2008	18
17	Hit-to-lead studies on benzimidazole inhibitors of ITK: Discovery of a novel class of kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Roger J. Snow,Bpantamars Phadungchob,Scot Campbell,John Lord,Mohammed A. Kashem,Xiao‐Peng Deng,Елена Логунова Витальевна,Jennifer A. Kowalski,Steven S. Pullen,Gilles Corrozet,Gregory P. Roth,Christopher R. Sarko,Noel S. Wilson,Michael P. Winters,John P. Wolak,Charles L. Cywin	2007	53
18	Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent European Journal of Immunology ·M. Albergamo,Steven S. Pullen,Donald Souza,Marilyn R. Kehry,Randolph J. Noelle	2002	32
19	The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells Nature Immunology ·Cory L. Ahonen,M. Albergamo,Loren D. Erickson,Brian P. O’Connor,Evan Lind,Steven S. Pullen,Marilyn R. Kehry,Randolph J. Noelle	2002	116
20	Structural and Biochemical Analysis of Signal Transduction by the TRAF Family of Adapter Proteins Cold Spring Harbor Symposia on Quantitative Biology ·Sarah M. McWhirter,Steven S. Pullen,Brian Werneburg,Mohamed Dyabi,Richard H. Ingraham,James J. Crute,Marilyn R. Kehry,Tom Alber	1999	9

About Steven S. Pullen

Steven S. Pullen is a scholar working on Cancer Research, Immunology, Nephrology, Molecular Biology and Immunology and Allergy, having authored 36 papers that have together received 2.2k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (11 papers), Immune Response and Inflammation (6 papers), interferon and immune responses (4 papers), Nitric Oxide and Endothelin Effects (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Immunotherapy and Immune Responses (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Nephrology (358 citations), Cancer Research (616 citations), Immunology (829 citations), Molecular Biology (1.0k citations) and Oncology (332 citations). Steven S. Pullen has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Marilyn R. Kehry, James J. Crute, Thu Thi Dang, Paul D. Friesen, Sarah M. McWhirter, Tom Alber, Heather G. Miller, Carine M. Boustany‐Kari, Katalin Suszták and James M. Holton. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Virology, Nature Medicine, Journal of Pharmacology and Experimental Therapeutics and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact